Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults

Kimberly A Fisher, Sarah J Bloomstone, Jeremy Walder, Sybil Crawford, Hassan Fouayzi, Kathleen M Mazor, Kimberly A Fisher, Sarah J Bloomstone, Jeremy Walder, Sybil Crawford, Hassan Fouayzi, Kathleen M Mazor

Abstract

Background: Coronavirus disease 2019 (COVID-19) has rapidly instigated a global pandemic. Vaccine development is proceeding at an unprecedented pace. Once available, it will be important to maximize vaccine uptake and coverage.

Objective: To assess intent to be vaccinated against COVID-19 among a representative sample of adults in the United States and identify predictors of and reasons for vaccine hesitancy.

Design: Cross-sectional survey, fielded from 16 through 20 April 2020.

Setting: Representative sample of adults residing in the United States.

Participants: Approximately 1000 adults drawn from the AmeriSpeak probability-based research panel, covering approximately 97% of the U.S. household population.

Measurements: Intent to be vaccinated against COVID-19 was measured with the question, "When a vaccine for the coronavirus becomes available, will you get vaccinated?" Response options were "yes," "no," and "not sure." Participants who responded "no" or "not sure" were asked to provide a reason.

Results: A total of 991 AmeriSpeak panel members responded. Overall, 57.6% of participants (n = 571) intended to be vaccinated, 31.6% (n = 313) were not sure, and 10.8% (n = 107) did not intend to be vaccinated. Factors independently associated with vaccine hesitancy (a response of "no" or "not sure") included younger age, Black race, lower educational attainment, and not having received the influenza vaccine in the prior year. Reasons for vaccine hesitancy included vaccine-specific concerns, a need for more information, antivaccine attitudes or beliefs, and a lack of trust.

Limitations: Participants' intent to be vaccinated was explored before a vaccine was available and when the pandemic was affecting a narrower swath of the United States. Questions about specific information or factors that might increase vaccination acceptance were not included. The survey response rate was 16.1%.

Conclusion: This national survey, conducted during the coronavirus pandemic, revealed that approximately 3 in 10 adults were not sure they would accept vaccination and 1 in 10 did not intend to be vaccinated against COVID-19. Targeted and multipronged efforts will be needed to increase acceptance of a COVID-19 vaccine when one becomes available.

Primary funding source: Agency for Healthcare Research and Quality.

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-3569.

Figures

Visual Abstract.. Attitudes Toward a Potential SARS…
Visual Abstract.. Attitudes Toward a Potential SARS CoV-2 Vaccine Among U.S. Adults
Once a vaccine for coronavirus disease 2019 becomes available, it will be important to maximize vaccine uptake and coverage. This national survey explores factors associated with vaccine hesitancy. The results suggest that multipronged efforts will be needed to increase acceptance of a coronavirus disease 2019 vaccine.

References

    1. World Health Organization. Coronavirus disease (COVID-19): situation report 106. World Health Organization; 2020. Accessed at on 9 May 2020.
    1. Nicola M, Alsafi Z, Sohrabi C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg. 2020;78:185-93. [PMID: 32305533] doi:10.1016/j.ijsu.2020.04.018
    1. Phua J, Weng L, Ling L, et al; Asian Critical Care Clinical Trials Group. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020;8:506-17. [PMID: 32272080] doi:10.1016/S2213-2600(20)30161-2
    1. Ipsos. What worries the world. April 2020. Accessed at on 7 May 2020.
    1. Ipsos. Topline & methodology. 2020. Accessed at on 9 May 2020
    1. Hajj Hussein I, Chams N, Chams S, et al. Vaccines through centuries: major cornerstones of global health. Front Public Health. 2015;3:269. [PMID: 26636066] doi:10.3389/fpubh.2015.00269
    1. Fine P, Eames K, Heymann DL. “Herd immunity”: a rough guide. Clin Infect Dis. 2011;52:911-6. [PMID: 21427399] doi:10.1093/cid/cir007
    1. Zhang J, Xie B, Hashimoto K. Current status of potential therapeutic candidates for the COVID-19 crisis. Brain Behav Immun. 2020;87:59-73. [PMID: 32334062] doi:10.1016/j.bbi.2020.04.046
    1. Kim E, Erdos G, Huang S, et al. Microneedle array delivered recombinant coronavirus vaccines: immunogenicity and rapid translational development. EBioMedicine. 2020;55:102743. [PMID: 32249203] doi:10.1016/j.ebiom.2020.102743
    1. Corum J, Grady D, Wee SL, et al. Coronavirus vaccine tracker. The New York Times. 2020. Accessed at on 26 August 2020.
    1. Salmon DA, Dudley MZ, Glanz JM, et al. Vaccine hesitancy: causes, consequences, and a call to action. Am J Prev Med. 2015;49:S391-8. [PMID: 26337116] doi:10.1016/j.amepre.2015.06.009
    1. Patel M, Lee AD, Clemmons NS, et al. National update on measles cases and outbreaks—United States, January 1-October 1, 2019. MMWR Morb Mortal Wkly Rep. 2019;68:893-6. [PMID: 31600181] doi:10.15585/mmwr.mm6840e2
    1. Hotez PJ. Texas and its measles epidemics. PLoS Med. 2016;13:e1002153. [PMID: 27780206] doi:10.1371/journal.pmed.1002153
    1. WHO releases list of 10 threats to global health. NEJM Journal Watch. 18 January 2019. Accessed at on 26 August 2020.
    1. Braun V, Clarke V. Thematic analysis. In: Cooper H, Camic PM, Long DL, et al, eds. APA Handbook of Research Methods in Psychology. Vol. 2. American Psychological Assoc; 2012:57-71.
    1. Institute for Health Metrics and Evaluation. COVID-19 projections. 2020. Accessed at on 6 May 2020.
    1. Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2018-19 influenza season. 26 September 2019. Accessed at on 6 May 2020.
    1. Hughes MM, Reed C, Flannery B, et al. Projected population benefit of increased effectiveness and coverage of influenza vaccination on influenza burden in the United States. Clin Infect Dis. 2020;70:2496-502. [PMID: 31344229] doi:10.1093/cid/ciz676
    1. Alimohamadi Y, Taghdir M, Sepandi M. Estimate of the basic reproduction number for COVID-19: a systematic review and meta-analysis. J Prev Med Public Health. 2020;53:151-7. [PMID: 32498136] doi:10.3961/jpmph.20.076
    1. Kelly B, Bann C, Squiers L, et al. Predicting willingness to vaccinate for COVID-19 in the US. JHC Impact. 12 May 2020. Accessed at on 10 July 2019.
    1. Paasche-Orlow MK, Parker RM, Gazmararian JA, et al. The prevalence of limited health literacy. J Gen Intern Med. 2005;20:175-84. [PMID: 15836552]
    1. Scott TL, Gazmararian JA, Williams MV, et al. Health literacy and preventive health care use among Medicare enrollees in a managed care organization. Med Care. 2002;40:395-404. [PMID: 11961474]
    1. Yancy CW. COVID-19 and African Americans. JAMA. 2020. [PMID: 32293639] doi:10.1001/jama.2020.6548
    1. Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 states, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458-64. [PMID: 32298251] doi:10.15585/mmwr.mm6915e3
    1. Gold JAW, Wong KK, Szablewski CM, et al. Characteristics and clinical outcomes of adult patients hospitalized with COVID-19—Georgia, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:545-50. [PMID: 32379729] doi:10.15585/mmwr.mm6918e1
    1. Vahidy FS, Nicolas JC, Meeks JR, et al. Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse U.S. metropolitan population. medRxiv. Preprint posted online 12 May 2020. doi:10.1101/2020.04.24.20073148
    1. Bibbins-Domingo K. This time must be different: disparities during the COVID-19 pandemic [Editorial]. Ann Intern Med. 2020;173:233-4. [PMID: 32343767] doi:10.7326/M20-2247
    1. Quinn SC, Hilyard KM, Jamison AM, et al. The influence of social norms on flu vaccination among African American and White adults. Health Educ Res. 2017;32:473-86. [PMID: 29220514] doi:10.1093/her/cyx070
    1. Freimuth VS, Jamison AM, An J, et al. Determinants of trust in the flu vaccine for African Americans and Whites. Soc Sci Med. 2017;193:70-9. [PMID: 29028558] doi:10.1016/j.socscimed.2017.10.001
    1. Karafillakis E, Larson HJ; ADVANCE consortium. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine. 2017;35:4840-50. [PMID: 28760616] doi:10.1016/j.vaccine.2017.07.061
    1. Bernstein S. Most Americans would take coronavirus vaccine if deemed safe: Reuters/Ipsos poll. Reuters Health News. 6 May 2020. Accessed at on 6 May 2020.
    1. McQueen A, Kreuter MW, Kalesan B, et al. Understanding narrative effects: the impact of breast cancer survivor stories on message processing, attitudes, and beliefs among African American women. Health Psychol. 2011;30:674-82. [PMID: 21895370] doi:10.1037/a0025395
    1. Larson HJ, Clarke RM, Jarrett C, et al. Measuring trust in vaccination: a systematic review. Hum Vaccin Immunother. 2018;14:1599-609. [PMID: 29617183] doi:10.1080/21645515.2018.1459252
    1. Trethewey SP. Strategies to combat medical misinformation on social media [Editorial]. Postgrad Med J. 2020;96:4-6. [PMID: 31732511] doi:10.1136/postgradmedj-2019-137201
    1. Lu PJ, Srivastav A, Amaya A, et al. Association of provider recommendation and offer and influenza vaccination among adults aged > =18 years—United States. Vaccine. 2018;36:890-8. [PMID: 29329685] doi:10.1016/j.vaccine.2017.12.016
    1. Wray RJ, Jupka K, Ross W, et al. How can you improve vaccination rates among older African Americans? J Fam Pract. 2007;56:925-9. [PMID: 17976341]
    1. Lemaitre T, Carrier N, Farrands A, et al. Impact of a vaccination promotion intervention using motivational interview techniques on long-term vaccine coverage: the PromoVac strategy. Hum Vaccin Immunother. 2019;15:732-9. [PMID: 30457421] doi:10.1080/21645515.2018.1549451
    1. Dempsey AF, Pyrznawoski J, Lockhart S, et al. Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial. JAMA Pediatr. 2018;172:e180016. [PMID: 29507952] doi:10.1001/jamapediatrics.2018.0016
    1. Jarrett C, Wilson R, O'Leary M, et al; SAGE Working Group on Vaccine Hesitancy. Strategies for addressing vaccine hesitancy—a systematic review. Vaccine. 2015;33:4180-90. [PMID: 25896377] doi:10.1016/j.vaccine.2015.04.040

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe